| Product Code: ETC8978720 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Romania Plasma Protein Therapeutics Market Overview |
3.1 Romania Country Macro Economic Indicators |
3.2 Romania Plasma Protein Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Romania Plasma Protein Therapeutics Market - Industry Life Cycle |
3.4 Romania Plasma Protein Therapeutics Market - Porter's Five Forces |
3.5 Romania Plasma Protein Therapeutics Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Romania Plasma Protein Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Romania Plasma Protein Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Romania leading to higher demand for plasma protein therapeutics |
4.2.2 Growing awareness and acceptance of plasma protein therapies among healthcare professionals and patients |
4.2.3 Advancements in biotechnology and research leading to the development of innovative plasma protein therapeutics |
4.3 Market Restraints |
4.3.1 High cost associated with plasma protein therapeutics limiting affordability for some patients |
4.3.2 Stringent regulatory requirements and approval processes for plasma protein products |
4.3.3 Limited availability of plasma donors and plasma collection centers in Romania |
5 Romania Plasma Protein Therapeutics Market Trends |
6 Romania Plasma Protein Therapeutics Market, By Types |
6.1 Romania Plasma Protein Therapeutics Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Romania Plasma Protein Therapeutics Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 Romania Plasma Protein Therapeutics Market Revenues & Volume, By Albumin, 2021- 2031F |
6.1.4 Romania Plasma Protein Therapeutics Market Revenues & Volume, By Immunoglobulin, 2021- 2031F |
6.1.5 Romania Plasma Protein Therapeutics Market Revenues & Volume, By Plasma-derived Factor VIII, 2021- 2031F |
6.1.6 Romania Plasma Protein Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Romania Plasma Protein Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Romania Plasma Protein Therapeutics Market Revenues & Volume, By Hemophilia, 2021- 2031F |
6.2.3 Romania Plasma Protein Therapeutics Market Revenues & Volume, By Primary Immunodeficiency Disorder (PIDD), 2021- 2031F |
6.2.4 Romania Plasma Protein Therapeutics Market Revenues & Volume, By Idiopathic Thrombocytopenic Purpura (ITP), 2021- 2031F |
6.2.5 Romania Plasma Protein Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
7 Romania Plasma Protein Therapeutics Market Import-Export Trade Statistics |
7.1 Romania Plasma Protein Therapeutics Market Export to Major Countries |
7.2 Romania Plasma Protein Therapeutics Market Imports from Major Countries |
8 Romania Plasma Protein Therapeutics Market Key Performance Indicators |
8.1 Patient adherence rates to plasma protein therapies |
8.2 Rate of adoption of novel plasma protein therapeutics in the market |
8.3 Number of clinical trials and research studies conducted on plasma protein therapies |
9 Romania Plasma Protein Therapeutics Market - Opportunity Assessment |
9.1 Romania Plasma Protein Therapeutics Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Romania Plasma Protein Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Romania Plasma Protein Therapeutics Market - Competitive Landscape |
10.1 Romania Plasma Protein Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Romania Plasma Protein Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |